An official website of the United States government Here’s how you know

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

In this section: Oncologic Drugs Advisory Committee

Briefing Information for the June 28-29, 2016 Meeting of the Pediatric Subcommittee of the Oncologic Drugs Advisory Committee (pedsODAC)

Persons with disabilities having problems accessing the PDF file(s) below may call (301) 796-3634 for assistance

June 28, 2016 - FDA

June 28, 2016 - AbbVie, Inc.

AbbVie Briefing Information for the June 28, 2016 Meeting of the Pediatric Subcommittee of the Oncologic Drugs Advisory Committee

June 28, 2016 - Epizyme, Inc.

Epizyme Briefing Information for the June 28, 2016 Meeting of the Pediatric Subcommittee of the Oncologic Drugs Advisory Committee

June 28, 2016 - Roche/Genentech

Genentech Briefing Information for the June 28, 2016 Meeting of the Pediatric Subcommittee of the Oncologic Drugs Advisory Committee

June 29, 2016 - Session One - FDA

FDA Briefing Information for the June 29, 2016 Meeting of the Pediatric Subcommittee of the Oncologic Drugs Advisory Committee (Session One)

June 29, 2016 - Loxo Oncology, Inc.

Loxo Briefing Information for the June 29, 2016 Meeting of the Pediatric Subcommittee of the Oncologic Drugs Advisory Committee

June 29, 2016 - Ignyta, Inc.

Ignyta Briefing Information for the June 29, 2016 Meeting of the Pediatric Subcommittee of the Oncologic Drugs Advisory Committee

June 29, 2016 - Session Two - FDA

FDA Briefing Information for the June 29, 2016 Meeting of the Pediatric Subcommittee of the Oncologic Drugs Advisory Committee (Session Two)

Top